Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity?
The LDN Book explains the drug’s origins, its primary mechanism, and the latest research from practicing physicians and pharmacists as compiled by Linda Elsegood of The LDN Research Trust, the world’s largest LDN charity organization with over 19,000 members worldwide. Featuring ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices, The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.
|Publisher:||Chelsea Green Publishing|
|Product dimensions:||5.90(w) x 8.90(h) x 0.70(d)|
About the Author
Linda Elsegood is the founder of the LDN Research Trust, which was set up in the UK as a Registered Charity in 2004, and is the editor of The LDN Book. Diagnosed with MS in August of 2000, she started LDN therapy in December of 2003, and now has a better quality of life and hope for the future. Through the Trust, she has connected thousands of patients, doctors, and pharmacists around the world with information, articles, and patient stories about LDN.
Table of Contents
Preface Linda Elsegood ix
Introduction Jill Cottel xv
Chapter 1 The History and Pharmacology of LDN J. Stephen Dickson 1
Chapter 2 Multiple Sclerosis and Lupus Deanna Windham 25
Chapter 3 Inflammatory Bowel Disease Jill P. Smith Leonard B. Weinstock 55
Chapter 4 Chronic Fatigue Syndrome and Fibromyalgia Kent Holtorf 69
Chapter 5 Thyroid Disorders Kent Holtorf 81
Chapter 6 Restless Legs Syndrome Leonard B. Weinstock Trisha L. Myers 99
Chapter 7 Depression Mark Shukhman Rebecca Shukhman 111
Chapter 8 Autism Spectrum Disorder Brian D. Udell 131
Chapter 9 Cancer Angus C. Dalgleish Wai M. Liu 143
Appendix A Starting the Conversation Mark H. Mandel 153
Appendix B Frequently Asked Questions about LDN Skip Lenz Julia Schopick 157